News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SCOLR Pharma, Inc. (DDD) Announces Receipt Of Milestone Payment From Wyeth Consumer Healthcare (WYE)



1/30/2007 1:01:00 PM

BELLEVUE, Wash.--(BUSINESS WIRE)--SCOLR Pharma, Inc. (Amex: DDD) announced today that it has received a second milestone payment under a previously disclosed License Agreement from Wyeth Consumer Healthcare, a division of Wyeth (NYSE: WYE). The cash payment under the SCOLR Pharma – Wyeth Consumer Healthcare agreement represents prepayment of a development milestone. SCOLR Pharma expects to report the payment as deferred research and development revenue for the quarter ending March 31, 2007.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES